Jonathan W. Wong

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Dynamic Profiling of Cell Free Tumour DNA in Aggressive B-Cell Lymphoma From Diagnosis to Transformation at Relapse.

Dynamic Profiling of Cell Free Tumour DNA in Aggressive B-Cell Lymphoma From Diagnosis to Transformation at Relapse.

Journal: EJHaem
Published: March 24, 2025

Infection risk and antimicrobial prophylaxis in bendamustine-treated patients with indolent non-Hodgkin lymphoma: An Australasian Lymphoma Alliance study.

Infection risk and antimicrobial prophylaxis in bendamustine-treated patients with indolent non-Hodgkin lymphoma: An Australasian Lymphoma Alliance study.

Journal: British journal of haematology
Published: December 20, 2023

Exploring the workplace and workforce intentions of early career physiotherapists in Australia.

Exploring the workplace and workforce intentions of early career physiotherapists in Australia.

Journal: Physiotherapy theory and practice
Published: November 28, 2023

Response to: Twelve tips for developing and maintaining a successful peer mentoring program for junior faculty in academic medicine.

Response to: Twelve tips for developing and maintaining a successful peer mentoring program for junior faculty in academic medicine.

Journal: Medical teacher
Published: November 28, 2022

Interventions to reduce infections in patients with hematological malignancies: a systematic review and meta-analysis.

Interventions to reduce infections in patients with hematological malignancies: a systematic review and meta-analysis.

Journal: Blood advances
Published: May 13, 2022

Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma.

Integrated clinical and genomic evaluation of guadecitabine (SGI-110) in peripheral T-cell lymphoma.

Journal: Leukemia
Published: November 23, 2021

Failure of tofacitinib to achieve an objective response in a DDX3X-MLLT10 T-lymphoblastic leukemia with activating JAK3 mutations.

Failure of tofacitinib to achieve an objective response in a DDX3X-MLLT10 T-lymphoblastic leukemia with activating JAK3 mutations.

Journal: Cold Spring Harbor molecular case studies
Published: November 19, 2019

The Effect of One-Abutment at One-Time on Marginal Bone Loss Around Implants Placed in Healed Bone: A Systematic Review of Human Studies.

The Effect of One-Abutment at One-Time on Marginal Bone Loss Around Implants Placed in Healed Bone: A Systematic Review of Human Studies.

Journal: Implant dentistry
Published: August 03, 2019

Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance.

Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance.

Journal: Blood advances
Published: May 17, 2019

Artemisinin and its derivatives: a potential treatment for leukemia.

Artemisinin and its derivatives: a potential treatment for leukemia.

Journal: Anti-cancer drugs
Published: December 13, 2018

Rapid and Durable Complete Remission of Refractory AITL with Azacitidine Treatment in Absence of TET2 Mutation or Concurrent MDS.

Rapid and Durable Complete Remission of Refractory AITL with Azacitidine Treatment in Absence of TET2 Mutation or Concurrent MDS.

Journal: HemaSphere
Published: December 02, 2018

Efficacy of Zanubrutinib in the Treatment of Bing-Neel Syndrome.

Efficacy of Zanubrutinib in the Treatment of Bing-Neel Syndrome.

Journal: HemaSphere
Published: August 06, 2018
Showing 1-12 of 13

Last Updated: 09/26/2026